Pravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
Glenmark Pharmaceuticals is voluntarily recalling Pravastatin Sodium 80mg tablets due to Current Good Manufacturing Practice deviations. The nationwide recall affects specific lot numbers and remains ongoing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall due to CGMP deviations. No illnesses or injuries have been reported in the source material. CGMP deviations represent manufacturing quality and process control concerns rather than identified health hazards, qualifying this as a precautionary voluntary recall typical of Moderate severity.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA, is voluntarily recalling Pravastatin Sodium Tablets, USP, 80mg, in both 90-count and 500-count bottles. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
The affected lots are 17221770, 17221774, 17231251, 17231262, 17232112, and 17232133, with expiration dates ranging from August 2025 through September 2026. The product was distributed nationwide throughout the United States.
Consumers taking Pravastatin Sodium from the affected lots should contact their healthcare provider or pharmacist to determine if their medication is part of this recall. Do not discontinue the medication without professional guidance.
This is a firm-initiated voluntary recall that remains ongoing. For more information, consumers should contact their pharmacist or the FDA.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Statin
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot # 17221770
- exp. date Aug-25 17221774
- exp. date Aug-25 17231251
- exp. date May-26 17231262
- exp. date May-26 17232112
- exp. date Sep-26 17232133
- exp. date Sep-26
UPCs (3)
- 0316714570013
- 0316714559018
- 0316714560014
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PRAVASTATIN SODIUM
- ModerateFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: Pravastatin Sodium Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateFDA recalls Glenmark Pravastatin Sodium tablets for manufacturing deviations
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
- HighPravastatin Sodium 80 mg tablets recalled for manufacturing deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27